Brief: Denovo Biopharma Llc Announces Partner Aytu Biopharma Receives FDA Clearance For Enzastaurin

Aytu Biopharma

14/12/2021 17:49

Dec 14 (Reuters) - Denovo Biopharma LLC:
    * DENOVO BIOPHARMA LLC ANNOUNCES PARTNER AYTU BIOPHARMA
RECEIVES
FDA CLEARANCE AND ORPHAN DRUG DESIGNATION FOR ENZASTAURIN IN
VASCULAR EHLERS-DANLOS SYNDROME
    * DENOVO BIOPHARMA- AYTU PLANS TO INITIATE PREVENT TRIAL IN
VEDS
IN FIRST HALF OF 2022

Source text for Eikon:  ID:nPnMzBzFa 
Further company coverage:  AYTU.O 

 ((Reuters.Briefs@thomsonreuters.com))